Andra AP-fonden’s AbbVie ABBV Stock Holding History

Andra AP-fonden’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.7M	Buy	283,811 +86,969	+44%	+$19.3M	0.74%	19
2025 Q4	$45M	Buy	196,842 +89,542	+83%	+$20.4M	0.56%	33
2025 Q3	$24.8M	Buy	107,300 +32,500	+43%	+$6.62M	0.32%	112
2025 Q2	$13.9M	Buy	74,800 +2,400	+3%	+$446K	0.19%	176
2025 Q1	$15.2M	Sell	72,400 -84,900	-54%	-$16.5M	0.25%	147
2024 Q4	$28M	Sell	157,300 -15,300	-9%	-$2.81M	0.45%	55
2024 Q3	$34.1M	Sell	172,600 -58,100	-25%	-$10.8M	0.5%	47
2024 Q2	$39.6M	Sell	230,700 -51,000	-18%	-$8.45M	0.66%	24
2024 Q1	$51.3M	Buy	281,700 +151,300	+116%	+$26.1M	0.91%	16
2023 Q4	$20.2M	Buy	130,400 +80,000	+159%	+$11.7M	1.07%	7
2023 Q3	$7.51M	Sell	50,400 -13,400	-21%	-$1.97M	0.44%	91
2023 Q2	$8.6M	Sell	63,800 -5,200	-8%	-$763K	0.22%	170
2023 Q1	$11M	Buy	69,000 +6,700	+11%	+$1.02M	0.29%	79
2022 Q4	$10.1M	Sell	62,300 -28,700	-32%	-$4.4M	0.31%	52
2022 Q3	$12.2M	Sell	91,000 -4,600	-5%	-$660K	0.4%	23
2022 Q2	$14.6M	Buy	+95,600	New	+$14.6M	0.42%	14
2021 Q4	$15.5M	Buy	114,800 +31,400	+38%	+$3.71M	0.32%	58
2021 Q3	$9M	Buy	+83,400	New	+$9.53M	0.19%	241
2021 Q2	–	Sell	-102,300	Closed	-$11.1M	–	595
2021 Q1	$11.1M	Sell	102,300 -9,700	-9%	-$1.04M	0.24%	130
2020 Q4	$12M	Sell	112,000 -10,800	-9%	-$1.04M	0.26%	71
2020 Q3	$10.8M	Buy	122,800 +100	+0.1%	+$9.41K	0.29%	43
2020 Q2	$12M	Buy	122,700 +22,600	+23%	+$1.99M	0.35%	7
2020 Q1	$7.63M	Buy	100,100 +300	+0.3%	+$25.6K	0.28%	22
2019 Q4	$8.84M	Sell	99,800 -11,400	-10%	-$946K	0.25%	27
2019 Q3	$8.42M	Buy	111,200 +21,400	+24%	+$1.47M	0.25%	31
2019 Q2	$6.53M	Buy	89,800 +6,200	+7%	+$487K	0.19%	188
2019 Q1	$6.74M	Buy	+83,600	New	+$6.84M	0.2%	172
2018 Q3	$8.73M	Sell	92,300 -5,100	-5%	-$484K	0.23%	122
2018 Q2	$9.02M	Buy	97,400 +14,000	+17%	+$1.37M	0.24%	70
2018 Q1	$7.89M	Buy	83,400 +6,900	+9%	+$758K	0.2%	141
2017 Q4	$7.4M	Sell	76,500 -11,000	-13%	-$1.04M	0.17%	166
2017 Q3	$7.78M	Buy	87,500 +12,915	+17%	+$983K	0.18%	150
2017 Q2	$5.41M	Buy	74,585 +7,885	+12%	+$530K	0.13%	208
2017 Q1	$4.35K	Buy	66,700 +9,500	+17%	+$597K	0.1%	292
2016 Q4	$3.58M	Sell	57,200 -15,800	-22%	-$964K	0.1%	339
2016 Q3	$4.6M	Sell	73,000 -1,500	-2%	-$97.1K	0.12%	258
2016 Q2	$4.61M	Sell	74,500 -15,300	-17%	-$932K	0.12%	245
2016 Q1	$5.13M	Sell	89,800 -8,500	-9%	-$474K	0.13%	201
2015 Q4	$5.82M	Sell	98,300 -22,900	-19%	-$1.32M	0.17%	158
2015 Q3	$6.59M	Buy	121,200 +2,900	+2%	+$189K	0.19%	137
2015 Q2	$7.95M	Sell	118,300 -33,800	-22%	-$2.21M	0.23%	125
2015 Q1	$8.9M	Sell	152,100 -30,500	-17%	-$1.84M	0.25%	105
2014 Q4	$11.9M	Sell	182,600 -105,500	-37%	-$6.65M	0.28%	95
2014 Q3	$16.6M	Buy	288,100 +89,800	+45%	+$4.99M	0.39%	58
2014 Q2	$11.2M	Sell	198,300 -248,000	-56%	-$13M	0.25%	121
2014 Q1	$22.9M	Buy	446,300 +46,400	+12%	+$2.35M	0.53%	31
2013 Q4	$21.1M	Buy	399,900 +33,500	+9%	+$1.65M	0.5%	34
2013 Q3	$16.4M	Buy	366,400 +1,600	+0.4%	+$70.9K	0.42%	46
2013 Q2	$15.1M	Buy	+364,800	New	+$16M	0.39%	45

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Andra AP-fonden's ABBV Position: Q1 2026 in Review

Andra AP-fonden increased its AbbVie (ABBV) stake by 44% in Q1 2026, buying an estimated $19.3M and bringing the position to 283,811 shares worth $61.7M. The position accounts for 0.74% of the portfolio, ranked #19.

Andra AP-fonden first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Andra AP-fonden held 283,811 shares of AbbVie worth $61.7M as of Q1 2026.
Andra AP-fonden bought 86,969 AbbVie shares in Q1 2026, an estimated $19.3M.
AbbVie made up 0.74% of Andra AP-fonden's portfolio in Q1 2026, its #19 holding.
Andra AP-fonden first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.